Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report from ExpreS2ion Biotech Holding AB’s (publ) annual general meeting

This is an unofficial translation of a report from the Annual General Meeting in ExpreS2ion Biotech Holding AB, originally drafted in Swedish. In case of any discrepancies between the Swedish original and this translation, the Swedish version shall prevail. Today, on May 23, 2019, the annual general meeting of ExpreS2ion Biotech Holding AB (publ) was held. A summary of the decisions that were made follows below. All decisions were taken with required majority.Distribution of results The AGM resolved to dispose of the Company's results according to the Board's proposal in the annual

Communiqué from Genovis AB (publ) Annual General Meeting May 23, 2019

The Annual General Meeting adopted the following resolutions:· The balance sheet and income statement were adopted. · The Board and the Chief Executive Officer were discharged from liability.  · The Board shall consist until the next AGM of six ordinary members without deputies.  · Ordinary members Kenth Petersson, Mikael Lönn, Lena Söderström, Peter Heinand Mårten Winge were re-elected. Lotta Ljungqvist and Håkan Wickholmwas elected new Board members.Mårten Winge was elected Chairperson of the Board.  · Remuneration will be paid to the Board of Directors in the amount

Funcom's First Quarter 2019 Financials

Financials · Revenues for the quarter increased by 117% to USD 5 812 thousand, versus same period last year (1Q18: USD 2 677 thousand)   · EBITDA increased by USD 2 467 thousand to USD 2 544 thousand (77) · EBIT increased by USD 1 265 thousand to USD 128 thousand (-1 138) · The equity increased by 31% to USD 45 955 thousand (35 137)   · The cash position increased by 19% to USD 19 614 thousand (16 533) · Cash flow from operating activities for the quarter increased by 572% to USD 4 102 thousand (611) Highlights · The first quarter of 2019 reports

AGM Statement

23 May 2019                              EnQuest PLC ("EnQuest" or the "Company")     Voting results of the Annual General Meeting held on 23 May 2019     EnQuest announces that at the Company's Annual General Meeting held today, all resolutions set out in the Notice of Annual General Meeting and put to the meeting were passed by the requisite majority by way of a poll.   The results of the poll are set out below. The number of ordinary shares in issue was 1,694,406,148.  Resolution  For *  %  Against  %  Withheld

Heimstaden issues bonds and announces early redemption and results from tender offer

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

SinterCast Annual General Meeting 2019

[Stockholm, 23 May 2019] – The SinterCast AB (publ) Annual General Meeting (AGM) was held on 23 May 2019 in Stockholm. During the AGM, Dr Steve Dawson, President & CEO, presented an overview of recent market activities and provided an outlook for the potential market development. Dr Dawson’s presentation commented on the recent growth from 2.5 million Engine Equivalents in 2018 to 3.4 million Engine Equivalents in March and April 2019. Dr Dawson expressed confidence in continued growth potential for each of the passenger vehicle, commercial vehicle and industrial power sectors, including

Contemplated sale of shares in Powercell AB

Press release Stockholm 23 May 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Carnegie Investment Bank AB (”Carnegie”) and Pareto Securities AB (“Pareto”) have been retained to explore the opportunity to sell approximately 5 million shares in Powercell AB (publ) ("Powercell") (the “Placing”). The shares are owned by Midroc New Technology, Fouriertransform and Finindus (“the Sellers”). The Sellers current holding

Save on Select California Attractions with Lodging Packages from California Inns

SACRAMENTO, CA [May 23, 2019]--Save on the price of admission with packages from California boutique hotels and B&Bs that include complimentary tickets to local attractions.  The California Association of Boutique and Breakfast Inns (CABBI.com) has compiled a list of inns around the state offering package deals for the Mendocino Coast Botanical Gardens, Palm Spring’s ShortFest film festival, and winetasting in Napa and the Santa Ynez Valley. Through the month of June, guests who stay three nights at Alegria Oceanfront Inn & Cottages  

Resurs Bank issues SEK 600 million of senior unsecured bonds

Resurs Bank AB, a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS), has issued SEK 600 million of senior unsecured bonds in the Nordic market. The 3 year bonds (with maturity May 2022) will be listed on Nasdaq Stockholm. The offer attracted very strong demand and resulted in an oversubscribed orderbook. The bonds are issued under Resurs Bank’s MTN programme with a total frame of SEK 8 billion and pays a coupon of 3m Stibor + 1.45%. Settlement date will be 31 May 2019 and maturity date 31 May 2022. Nordea and Swedbank acted as joint book runners in the

Resurs Bank issues SEK 600 million of senior unsecured bonds

Resurs Bank AB has issued SEK 600 million of senior unsecured bonds in the Nordic market. The 3 year bonds (with maturity May 2022) will be listed on Nasdaq Stockholm. The offer attracted very strong demand and resulted in an oversubscribed orderbook. The bonds are issued under Resurs Bank’s MTN programme with a total frame of SEK 8 billion and pays a coupon of 3m Stibor + 1.45%. Settlement date will be 31 May 2019 and maturity date 31 May 2022. Nordea and Swedbank acted as joint book runners in the transaction. For additional information:Peter Rosén, CFO & Head of IR, peter.

Multiconsult ASA - Mandatory notification of trade

The following primary insider in Multiconsult ASA sold shares in Multiconsult ASA:Øyvind Holtedahl, EVP Marketing, Strategy & Innovation, has on 23 May 2019 sold 13 790 shares in Multiconsult ASA at a price of NOK 64.27 per share and will after the transaction hold 12 525 shares in Multiconsult ASA.For further information, please contact: Investor relations:         Mirza Koristovic, Head of Investor Relations         Phone: +47 93 87 05 25         E-mail: ir@multiconsult.noMedia:         Gaute Christensen, VP Communications         Phone: +47 911 70 188         E-mail:

TARGOVAX ASA - APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Oslo, 23 May 2019: Reference is made to the stock exchange announcement by Targovax ASA (OSE:TRVX) ("Targovax" or the "Company") on 8 May 2019, regarding the completion of the enrollment of the ONCOS-102 trial in

Q1 2019 Report - Ayima Group AB (Pub)

Highlights YTD: Jan - Mar 2019 ·Total Revenue amounted to 36.4 MSEK (41.0) a decrease of 11.3% from the corresponding period in 2018 ·Gross Profit amounted to 26.2 MSEK (22.1) an increase of 18.1% from the same period in 2018 ·A positive EBITDA result of 0.6 MSEK, the same result as in the corresponding period in 2018 ·Total Comprehensive Income (after tax and exceptional items) amounted to -1.8 MSEK (2.3). Extraordinary charges relate to restructuring and other one-off adjustments required under IFRS ·Balance Sheet assets amounted to 163.7 MSEK (61.7)

ALGIZ 10X Joins Extreme Atlantic Ocean Rowing Race

Talisker Whisky Atlantic Challenge The Algiz 10X  rugged tablet joined the Wight Lightning rowing team in the 2017-2018 Talisker Whisky race across the Atlantic Ocean. Will Whitehead, a member of the Wight Lightning team tells the story: “In December 2017, our four-man crew set off from La Gomera in the Canary Islands to row 3000 miles across the Atlantic Ocean to Antigua in the Caribbean. We entered into a race called the Talisker

#19-915 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Jacob EhrnroothPosition:                                  Chairman of the Board Notification type:                    Initial notificationIssuer Name:                            Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                     2019-05-23 Venue:                          First North Sweden (FNSE)Nature of transaction:              Acceptance of a stock option 2/2019A Instrument:                              Share option

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Johan BiehlPosition:                                  Member of the Board Notification type:                    Initial notificationIssuer Name:                            Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                     2019-05-23 Venue:                          First North Sweden (FNSE)Nature of transaction:              Acceptance of a stock option 2/2019A Instrument:                              Share option

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Oliver KernPosition:                                  Member of the Board Notification type:                    Initial notificationIssuer Name:                            Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                     2019-05-23 Venue:                          First North Sweden (FNSE)Nature of transaction:              Acceptance of a stock option 2/2019A Instrument:                              Share option

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Sverker LittorinPosition:                                  Member of the Board Notification type:                    Initial notificationIssuer Name:                            Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                     2019-05-23 Venue:                          First North Sweden (FNSE)Nature of transaction:              Acceptance of a stock option 2/2019A Instrument:                              Share option

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                          Wilhelm TahtPosition:                                  Member of the Board Notification type:                    Initial notificationIssuer Name:                            Nitro Games OyjLEI:                             743700XPEJZPMWDULF59Transaction detailsTransaction date:                     2019-05-23 Venue:                          First North Sweden (FNSE)Nature of transaction:              Acceptance of a stock option 2/2019A Instrument:                              Share option

Cyxone submits application to start first-in-human trial with T20K in MS

Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company has set a date for the application submission for the start of clinical trials with T20K. On Monday May 27, an application to the relevant authorities to start a first-in-human, phase I, clinical trial with drug candidate T20K in multiple sclerosis (MS) will be submitted. The company will subsequently await a response from the authorities before the study can be initiated as planned during the second quarter of 2019.The application to start the first-in-human clinical trial for T20K in MS will on

Ismotec: “Today there’s no IT-project without integration”

Higher demands for seamless data flows and up-to-date information – to run a successful business and make the right decisions, you need instant access to information about your business transactions and the markets. – Companies today want to see and do everything on the same platform – from checking current stock balances to placing orders directly in the system. The demand for smarter integration solutions gets higher and higher, says Nicklas Andersson, Integration Architect at Ismotec. Nicklas Andersson, Integration Architect at Ismotec Since its inception in 2006, ERP

Inhalation Sciences AB (publ) initiates study to validate PreciseInhale for clinical use

(STOCKHOLM, SWEDEN - May 23, 2019) The Board of Inhalation Sciences (ISAB) has decided to initiate and invest in a clinical study to validate PreciseInhale for clinical use. Technical and regulatory validation is expected to take about 15 months, and will be fully financed through the divestment of a small part of ISAB's holdings in Ziccum AB.In several pre-clinical Contract Research studies ISAB has successfully delivered clear indications of IVIVC, or In Vitro In Vivo Correlation, when pre-clinical data generated by its pre-clinical modules including DissolvIt have proved to accurately

Appoints Mangold as Liquidity Provider

Cereno Scientific AB (”Cereno Scientific” or “the Company”) has appointed Mangold Fondkommission as liquidity provider for the company's shares of series B listed on Spotlight Stock Market.The purpose of the liquidity provider is to improve the liquidity of the share and reduce the difference between the buying and selling price. The assignment commences on May 24, 2019. Mangold will fulfill its assignment as liquidity provider to ensure the possibility of trading in Cereno Scientific’s share every day by continuously placing trading records on each purchase and sales page in the order

There are no items matching the current filter
There are no more items matching the current filter
Back to top